Nectar Lifesciences Limited (LUX: NECLF)
Luxembourg
· Delayed Price · Currency is EUR · Price in USD
0.414
0.00 (0.00%)
At close: Nov 19, 2024
Nectar Lifesciences Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
Net Income | 107.27 | 49.95 | -241.83 | 250.47 | -732.64 | 317.89 | Upgrade
|
Depreciation & Amortization | 610.82 | 607.18 | 591.19 | 569.68 | 602.53 | 607.66 | Upgrade
|
Loss (Gain) From Sale of Assets | - | - | -404.08 | -94.07 | 1.31 | - | Upgrade
|
Loss (Gain) From Sale of Investments | -1.8 | -1.8 | -1.05 | -0.03 | -0.4 | -0.39 | Upgrade
|
Provision & Write-off of Bad Debts | 26.41 | 9.33 | 2.23 | 9.65 | -54.75 | 18.34 | Upgrade
|
Other Operating Activities | 1,046 | 893.53 | 610.79 | 859.77 | 803.16 | 1,203 | Upgrade
|
Change in Other Net Operating Assets | -201.31 | 688.67 | 779.26 | -645.42 | -405.42 | 703.6 | Upgrade
|
Operating Cash Flow | 1,588 | 2,247 | 1,337 | 950.05 | 213.79 | 2,850 | Upgrade
|
Operating Cash Flow Growth | -10.07% | 68.11% | 40.68% | 344.38% | -92.50% | 19.11% | Upgrade
|
Capital Expenditures | -221.57 | -294.15 | -300.6 | -249.7 | -312.41 | -547.69 | Upgrade
|
Sale of Property, Plant & Equipment | - | - | 797.88 | 397.31 | 1.85 | 185.27 | Upgrade
|
Investment in Securities | - | - | 2.5 | - | -2.5 | 4.14 | Upgrade
|
Other Investing Activities | 25.49 | 123.9 | 17.26 | 18.83 | 26.82 | 27.01 | Upgrade
|
Investing Cash Flow | -196.08 | -170.25 | 517.04 | 166.44 | -286.24 | -331.27 | Upgrade
|
Short-Term Debt Issued | - | - | - | - | 922.92 | - | Upgrade
|
Long-Term Debt Issued | - | 4.12 | 0.01 | 1,568 | 330.82 | 3.34 | Upgrade
|
Total Debt Issued | 359.4 | 4.12 | 0.01 | 1,568 | 1,254 | 3.34 | Upgrade
|
Short-Term Debt Repaid | - | -466.94 | -438.58 | -2,063 | - | -162.56 | Upgrade
|
Long-Term Debt Repaid | - | -720.11 | -652.39 | -10.28 | -7.28 | -1,088 | Upgrade
|
Total Debt Repaid | -880.95 | -1,187 | -1,091 | -2,073 | -7.28 | -1,250 | Upgrade
|
Net Debt Issued (Repaid) | -521.55 | -1,183 | -1,091 | -505.69 | 1,246 | -1,247 | Upgrade
|
Common Dividends Paid | - | - | - | - | -11.21 | -11.21 | Upgrade
|
Other Financing Activities | -887.85 | -871.42 | -764.87 | -688.11 | -1,120 | -1,261 | Upgrade
|
Financing Cash Flow | -1,409 | -2,054 | -1,856 | -1,194 | 114.9 | -2,519 | Upgrade
|
Net Cash Flow | -17.96 | 22.26 | -2.28 | -77.31 | 42.45 | -0.34 | Upgrade
|
Free Cash Flow | 1,366 | 1,953 | 1,036 | 700.35 | -98.62 | 2,302 | Upgrade
|
Free Cash Flow Growth | -7.29% | 88.50% | 47.91% | - | - | 14.46% | Upgrade
|
Free Cash Flow Margin | 8.18% | 11.59% | 6.80% | 4.20% | -0.64% | 9.73% | Upgrade
|
Free Cash Flow Per Share | 5.99 | 8.71 | 4.62 | 3.12 | -0.44 | 10.26 | Upgrade
|
Cash Interest Paid | 871.42 | 871.42 | 794.87 | 788.1 | 1,120 | 1,258 | Upgrade
|
Cash Income Tax Paid | - | - | - | - | 37.13 | 95.62 | Upgrade
|
Levered Free Cash Flow | 286.59 | 970.9 | 259.57 | -492.06 | 2,091 | 1,303 | Upgrade
|
Unlevered Free Cash Flow | 857 | 1,531 | 777.06 | -54.91 | 2,627 | 1,876 | Upgrade
|
Change in Net Working Capital | 178.3 | -637.76 | -518.79 | 1,010 | -2,025 | -820.64 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.